Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1979 Jul;37(3):631–636.

Age-related difference by IgG subclass in the response of mice to allogeneic spleen cells

T N Harris, Susanna Harris
PMCID: PMC1457732  PMID: 500120

Abstract

Inbred mice of various strains, 3–4 months of age and 16 months or older, were given primary injections of allogeneic spleen cells to observe the time of appearance and relative levels of alloantibodies of IgG1 and IgG2 class. In 3–4 month old C3H mice injected with BALB/c spleen cells, IgG2 alloantibodies were present on day 6, before the appearance of alloantibodies of IgG1 class. The IgG2 class alloantibodies then continued to increase in level until day 12. IgG1 class antibodies, which appeared after day 6, also increased during this period. When C3H mice at 16 months of age were similarly injected a difference in response was found in that IgG2 class alloantibodies did not increase in level after the appearance of those of the IgG1 class, but IgG1 class alloantibodies increased until day 12, as in the young mice. At intermediate ages smaller effects in the same directions were observed. Young BALB/c mice injected with C3H spleen cells gave responses similar to those of the young C3H mice. At 16 months, however, the response was not different from that of the young BALB/c mice. At older ages (19–25 months) the response of BALB/c mice was similar to that of the 16-month-old C3H mice described above. CBA mice of various ages which were injected with BALB/c spleen cells showed effects similar to that of the BALB/c mice in that a change of response seen in the older CBA mice, similar to that of the other two strains, did not appear at 16 months of age but did appear later (20–24 months).

Full text

PDF
631

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cheney K. E., Walford R. L. Immune function and dysfunction in relation to aging. Life Sci. 1974 Jun 1;14(11):2075–2084. doi: 10.1016/0024-3205(74)90090-3. [DOI] [PubMed] [Google Scholar]
  2. Doria G., D'Agostaro G., Poretti A. Age-dependent variations of antibody avidity. Immunology. 1978 Oct;35(4):601–611. [PMC free article] [PubMed] [Google Scholar]
  3. Goidl E. A., Innes J. B., Weksler M. E. Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med. 1976 Oct 1;144(4):1037–1048. doi: 10.1084/jem.144.4.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goodman S. A., Makinodan T. Effect of age on cell-mediated immunity in long-lived mice. Clin Exp Immunol. 1975 Mar;19(3):533–542. [PMC free article] [PubMed] [Google Scholar]
  5. Han I. H., Johnson A. G. Regulation of the immune system by synthetic polynucleotides. VI. Amplification of the immune response in young and aging mice. J Immunol. 1976 Aug;117(2):423–427. [PubMed] [Google Scholar]
  6. Harris S., Harris T. N. Suppression of rabbit lymph node cells by rabbit anti-leucocyte serum demonstrated in vitro by the antibody plaque test. J Immunol. 1966 Mar;96(3):478–487. [PubMed] [Google Scholar]
  7. Harris T. N., Harris S. Effect of anti-mouse IgG on some complement-requiring alloantibodies of the mouse. J Immunol. 1972 Nov;109(5):1096–1108. [PubMed] [Google Scholar]
  8. Harris T. N., Harris S. Fate of skin allografts in normal mice injected with antigraft strain globulin in relation to the IgG1 and IgG2 class of the antibodies. Immunology. 1973 Sep;25(3):409–421. [PMC free article] [PubMed] [Google Scholar]
  9. Harris T. N., Harris S., Henri E. M. A preparation of Fc fragment of normal mouse IgG1 for production of rabbit anti mouse IgG1 serum. J Immunol Methods. 1975 Sep;8(3):203–212. doi: 10.1016/0022-1759(75)90113-1. [DOI] [PubMed] [Google Scholar]
  10. Harris T. N., Harris S. Shifts from IgG-2 class to IgG-1 class in CBA and C3H anti-BALB/c antibody. Transplantation. 1975 Apr;19(4):318–325. doi: 10.1097/00007890-197504000-00007. [DOI] [PubMed] [Google Scholar]
  11. Kay M. M. Effect of age on T cell differentiation. Fed Proc. 1978 Apr;37(5):1241–1244. [PubMed] [Google Scholar]
  12. Kishimoto S., Takahama T., Mizumachi H. In vitro immune response to the 2,4,6-trinitrophenyl determinant in aged C57BL/6J mice:changes in the humoral immune response to, avidity for the TNP determinant and responsiveness to LPS effect with aging. J Immunol. 1976 Feb;116(2):294–300. [PubMed] [Google Scholar]
  13. Konen T. G., Smith G. S., Walford R. L. Decline in mixed lymphocyte reactivity of spleen cells from aged mice of a long-lived strain. J Immunol. 1973 May;110(5):1216–1221. [PubMed] [Google Scholar]
  14. Krogsrud R. L., Perkins E. H. Age-related changes in T cell function. J Immunol. 1977 May;118(5):1607–1611. [PubMed] [Google Scholar]
  15. MAKINODAN T., PETERSON W. J. Relative antibody-forming capacity of spleen cells as a function of age. Proc Natl Acad Sci U S A. 1962 Feb;48:234–238. doi: 10.1073/pnas.48.2.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Makinodan T., Adler W. H. Effects of aging on the differentiation and proliferation potentials of cells of the immune system. Fed Proc. 1975 Feb;34(2):153–158. [PubMed] [Google Scholar]
  17. Makinodan T., Albright J. W., Good P. I., Peter C. P., Heidrick M. L. Reduced humoral immune activity in long-lived old mice: an approach to elucidating its mechanisms. Immunology. 1976 Dec;31(6):903–911. [PMC free article] [PubMed] [Google Scholar]
  18. Makinodan T., Peterson W. J. Secondary antibody-forming potential of mice in relation to age--its significance in senescence. Dev Biol. 1966 Aug;14(1):96–111. doi: 10.1016/0012-1606(66)90007-8. [DOI] [PubMed] [Google Scholar]
  19. Naor D., Bonavida B., Walford R. L. Autoimmunity and aging: the age-related response of mice of a long-lived strain to trinitrophenylated syngeneic mouse red blood cells. J Immunol. 1976 Dec;117(6):2204–2208. [PubMed] [Google Scholar]
  20. Nordin A. A., Makinodan T. Humoral immunity in aging. Fed Proc. 1974 Sep;33(9):2033–2035. [PubMed] [Google Scholar]
  21. Price G. B., Makinodan T. Immunologic deficiencies in senescence. I. Characterization of intrinsic deficiencies. J Immunol. 1972 Feb;108(2):403–412. [PubMed] [Google Scholar]
  22. Segre M., Segre D. Humoral immunity in aged mice. I. Age-related decline in the secondary response to DNP of spleen cells propagated in diffusion chambers. J Immunol. 1976 Mar;116(3):731–734. [PubMed] [Google Scholar]
  23. Shigemoto S., Kishimoto S., Yamamura Y. Change of cell-mediated cytotoxicity with aging. J Immunol. 1975 Jul;115(1):307–309. [PubMed] [Google Scholar]
  24. Singhal S. K., Roder J. C., Duwe A. K. Suppressor cells in immunosenescence. Fed Proc. 1978 Apr;37(5):1245–1252. [PubMed] [Google Scholar]
  25. TELLER M. N., CURLETT W., KUBISEK M. L., CURTIS D., STOHR G. AGING AND CANCERIGENESIS. I. IMMUNITY TO TUMOR AND SKIN GRAFTS. J Natl Cancer Inst. 1964 Oct;33:649–656. [PubMed] [Google Scholar]
  26. Walford R. L. Immunologic theory of aging: current status. Fed Proc. 1974 Sep;33(9):2020–2027. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES